Results 181 to 190 of about 4,177,143 (225)

Closing the drug lag for new drug submission and review in Japan: An industry perspective

Clinical pharmacology and therapy, 2015
Af Poirier
semanticscholar   +1 more source

The Drug Lag: Good or Bad?

Journal of the American Pharmaceutical Association (1961), 1977
openaire   +2 more sources

Relationship between drug lag and factors associated with clinical trials in Japan

Journal of Clinical Pharmacy and Therapeutics, 2014
K. Ohwaki, T. Nakabayashi
semanticscholar   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in Japan

Clinical pharmacology and therapy, 2014
T. Ueno, Y. Asahina, A. Tanaka, H. Yamada, M. Nakamura, Y. Uyama   +5 more
semanticscholar   +1 more source

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
H S L Jim, Aasha I Hoogland, Naomi C Brownstein   +2 more
exaly  

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly  

Recent progress in pancreatic cancer

Ca-A Cancer Journal for Clinicians, 2013
Christopher L Wolfgang, Daniel A Laheru, Elliot Fishman   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly